Professor Victor van Beusechem, Ph.D.

Chief Scientific Officer (CSO)

Victor van Beusechem brings more than 25 years of biomedical R&D experience to ORCA. He invented new technologies and developed innovative scientific approaches to optimize virus-based gene and anti-cancer therapies with his research teams at TNO in Rijswijk, at Introgene BV (now Crucell) in Leiden and at VU University Medical Center in Amsterdam. Besides CSO of ORCA, he is Professor of Applied Molecular Oncology, head of the Oncogenomics Laboratory of the department of Medical Oncology, and director of the RNA Interference Functional Oncogenomics Laboratory, at the VU University Medical Center. He graduated in Medical Biology, and received a PhD (Cum Laude) in gene therapy at Leiden University.